Further statistical analysis of PO4-SMAD2/3 levels and their association with pathological features of cSCC demonstrate that increasing tumour depth (a known risk factor for nodal metastasis and poor prognosis) independently predicts a reduction in canonical TGF-β signalling activity. The gene discussed is SMAD2; the disease is skin squamous cell carcinoma.